ABSTRACT

The outbreak of SARS Corona virus has affected a huge population across the globe specifically people with weak immunity. The global pandemic of COVID – 19 has surpassed all previous pandemics in terms total contaminated population and the mortality rate. This review article discusses the current status of intranasal drug delivery systems being used for the administration of various antiviral drugs. Further it includes advantages and disadvantages of drug delivery system with emphasis of future applications to manage COVID – 19 and similar situations. Keywords: Corona pandemic, COVID – 19, Intranasal drug delivery systems, Antiviral drugs
Publication date: 01/09/2021

https://ijbpas.com/pdf/2021/September/MS_IJBPAS_2021_5595.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.9.5595